Xi'an ruixi Biological Technology Co

Home > Keywords >

Catalog	name	Description	price
R-C-7033	Lyophosome made from Unsaturated (PC)(14:1 (Δ9-Trans)PC:Cholesterol(70:30 molar-ratio)	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(14:1 (Δ9-Trans)PC:Cholesterol(70:30 molar ratio))Based on the liposome cell membrane fusion mechanism, hydrophobic drugs(such as paclitaxel and insulin) can be encapsulated and released through endocytosis,reducing systemic toxicity.	price>
R-M-6038	Glucose -PEG400-NHS	Glucose-PEG-NHS is a linear heterobifunctional PEG reagent with Glucose and NHS group, Primary NHS groups can use to react with Amine groups.	price>
R-C-5454	PEI1800-Se-Se-PEG20k	The PEI1800-Se-Se-PEG conjugate combines these three components to create an efficient and controlled gene delivery system. The positively charged PEI1800 core condenses the nucleic acids, protecting them from degradation and facilitating cellular uptake. The Se-Se linkage allows for redox-responsive release of the genetic material within the cells, ensuring efficient intracellular delivery. This product is only suitable for scientific research and is not intended for human body research.	price>
R-C-5554	DSPE-polysarcosine66	DSPE-polysarcosine66 is a phospholipid polyPEG which can self-assemble to form lipid bilayer in aqueous solution. Polysarcosine is poly (n-methylated glycine) that is is a non-ionic hydrophilic polypeptoid with numerous biologically relevant properties. The polymer can be used to prepare liposome as a drug delivery vehicle for administration of drugs or nutrients, such as mRNA vaccines.	price>
R-M2-9472	DMG-PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC	DMG-PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC represents a sophisticated bioconjugate with multifaceted applications in targeted drug delivery, cancer therapy, tissue engineering, and biological research. The synergistic effect of each component — DMG for stabilization, PEG for solubility and circulation, the peptide for specific targeting, and FITC for visualization — makes this construct a valuable tool in both research and clinical settings.	price>
R-C-7034	Lyophosome made from Unsaturated (PC)(16:1 (Δ9-Cis) PC: Cholesterol (70:30 molar ratio))	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(16:1 (Δ9-Cis) PC: Cholesterol (70:30 molar ratio)),Lyophosome made from Unsaturated Phosphatidylcholine(PC)(16:1 (Δ9-Cis)PC: Cholesterol(70:30 molar ratio))Used for membrane biology research,simulating cell membrane behavior to explore the regulatory mechanism of cholesterol on fluidity or signaling pathways(such as mTORC1).	price>
R-M-6039	N-hydroxylsuccinimide-PEG600-Glucose	Glucose-PEG-NHS is a linear heterobifunctional PEG reagent with Glucose and NHS group, Primary NHS groups can use to react with Amine groups.	price>
R-C-5455	DSPE-PEG2000-hemin	The DSPE-PEG2000 portion provides stability, prolonged circulation, and biocompatibility to the lipid-based delivery system. The attachment of hemin moieties enables targeted therapy, utilizing the unique properties of hemin for cancer treatment.This conjugate holds promise for targeted drug delivery and therapy, utilizing the properties of hemin to enhance treatment efficacy in conditions such as cancer.This product is only suitable for scientific research and is not intended for human body research.	price>
R-C-5555	16:0 PE MCC	16:0 PE MCC is a maleimide-functionalized thiol-reactive lipid with a phosphoethanolamine linked to two palmitic acid tails and a maleimide group.	price>
R-M2-9473	FITC-TFYGGRPKRNNFLRGIRSRGD	FITC-TFYGGRPKRNNFLRGIRSRGD is a potent bioconjugate for applications in targeted therapy, cell tracking, and cellular interaction studies. The RGD motif’s ability to mediate integrin interactions, combined with the fluorescence properties of FITC, offers significant advantages for cell-targeted applications in research and therapeutic contexts.	price>
R-C-7035	Lyophosome made from Unsaturated (PC)(16:1 (Δ9-Trans) PC: Cholesterol (70:30 molar ratio))	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(16:1(Δ9-Trans)PC: Cholesterol(70:30 molar ratio)),Liposomes are composed of 70 mol% 16:1(Δ 9-Trans)PC (a trans configured unsaturated phosphatidylcholine)and 30 mol% cholesterol,ensuring membrane structure stability and optimizing fluidity,suitable for membrane biology research.	price>
R-M-6040	Glucose-PEG200-Biotin	Glucose-PEG-Biotin is a linear heterobifunctional PEG reagent with Glucose and Biotin group.	price>
R-C-5456	DSPE-PEG-YIGSR	DSPE-PEG-YIGSR creates a conjugate that possesses both cell-targeting and biomaterial properties. The DSPE and PEG portions provide stability, biocompatibility, and prolonged circulation to the liposomal delivery system. The attachment of the YIGSR peptide sequence enables specific cell targeting and interaction with integrin receptors, promoting cell adhesion and tissue regeneration.	price>
R-C-5556	18:1 PE MCC	18:1 PE MCC is a maleimide-functionalized thiol-reactive lipid with a phosphoethanolamine linked to two oleic acid and a maleimide group.	price>
R-M2-9474	DMG-PEG5000-CFP10(71-85)(EISTNIRQAGVQYSR)	DMG-PEG5000-CFP10(71-85)(EISTNIRQAGVQYSR) is a versatile bioconjugate that combines elements for improving solubility and stability with a biologically relevant peptide sequence from the Mycobacterium tuberculosis CFP10 protein. Its applications span vaccine development, diagnostics, and drug delivery, making it a valuable tool in both research and therapeutic contexts.	price>
R-C-7036	Lyophosome made from Unsaturated PC(18:1 (Δ6-Cis) PC: Cholesterol (70:30 molar ratio))	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(18:1 (Δ6-Cis) PC: Cholesterol (70:30 molar ratio)),18:1(Δ6-Cis)PC belongs to monounsaturated phosphatidylcholine,and its cis configuration(Δ6-Cis)is more stable under physiological conditions.Its complex ratio with cholesterol(70:30)is commonly used in liposome construction to enhance membrane fluidity and drug encapsulation efficiency.	price>
R-M-6041	Biotin-PEG300-Glucose	Glucose-PEG-Biotin is a linear heterobifunctional PEG reagent with Glucose and Biotin group.	price>
R-C-5457	PLGA-SS-PEG-AANL-KLVFFK(GGDGR)YIGSR MW:7600,2000 PLGA:75/25	PLGA-SS-PEG-AANL-KLVFFK(GGDGR)YIGSR creates a drug delivery system that possesses controlled-release capabilities, targeting functionalities, and cell adhesive properties. The PLGA core enables encapsulation of drugs while the SS bond allows for controlled drug release under reducing conditions. The PEG layer improves stability, solubility, and circulation time. The AANL peptide sequence serves as a targeting ligand, enabling specific delivery to cells overexpressing the corresponding receptor.	price>
R-C-5557	16:0 MPB PE	The MPB-PE component refers to the specific type of phosphoethanolamine (PE) headgroup present in the molecule. The MPB modification stands for the insertion of an N-myristoyl group (myristoyl refers to a 14-carbon saturated fatty acid) and a C-palmitoyl group (palmitoyl refers to a 16-carbon saturated fatty acid) within the ethanolamine moiety of the phospholipid.	price>
R-M2-9475	PEG5000-CFP10(71-85)(EISTNIRQAGVQYSR)	PEG5000-CFP10(71-85)(EISTNIRQAGVQYSR)/PEG5k-EISTNIRQAGVQYSR is a versatile bioconjugate that combines a polyethylene glycol moiety with an immunologically relevant peptide. Its design is aimed at improving the solubility, stability, and presentation of the peptide for potential use in vaccine development, diagnostics, and therapeutic applications in immunology.	price>

101510161017101810191020 10211022102310241025